Key considerations in the pharmacotherapy of tuberculous meningitis. Wasserman, S., Davis, A. G, Wilkinson, R. J, & Meintjes, G. A Expert Opinion on Pharmacotherapy, 20(15):1791–1795, Taylor & Francis, jul, 2019.
Key considerations in the pharmacotherapy of tuberculous meningitis [link]Paper  doi  bibtex   
@article{Wasserman2019b,
author = {Wasserman, Sean and Davis, Angharad G and Wilkinson, Robert J and Meintjes, Graeme A},
doi = {10.1080/14656566.2019.1638912},
file = {:C$\backslash$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Wasserman et al. - 2019 - Key considerations in the pharmacotherapy of tuberculous meningitis.pdf:pdf},
journal = {Expert Opinion on Pharmacotherapy},
keywords = {editorial,fund{\_}ack},
mendeley-tags = {editorial,fund{\_}ack},
month = {jul},
number = {15},
pages = {1791--1795},
pmid = {31305179},
publisher = {Taylor {\&} Francis},
title = {{Key considerations in the pharmacotherapy of tuberculous meningitis}},
url = {https://www.tandfonline.com/doi/full/10.1080/14656566.2019.1638912},
volume = {20},
year = {2019}
}

Downloads: 0